Sean Lee
Stock Analyst at HC Wainwright & Co.
(2.3)
# 724
Out of 5,318 analysts
106
Total ratings
38.98%
Success rate
34.77%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DWTX Dogwood Therapeutics | Upgrades: Buy | 10 | 5.74 | 74.22% | 1 | Apr 23, 2025 | |
ATEC Alphatec Holdings | Reiterates: Buy | 20 20 | 11.4 | 75.44% | 12 | Apr 14, 2025 | |
CASI CASI Pharmaceuticals | Maintains: Buy | 6 4 | 2.04 | 96.08% | 8 | Apr 9, 2025 | |
CTSO CytoSorbents | Reiterates: Neutral | 1 1 | 1.12 | -10.71% | 12 | Apr 3, 2025 | |
MNPR Monopar Therapeutics | Reiterates: Buy | 40 40 | 42.71 | -6.35% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 0.86 | 539.53% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 3.69 | 198.1% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 7.5 | 33.33% | 13 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 10 | n/a | n/a | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | n/a | n/a | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.44 | 1983.33% | 1 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |